Literature DB >> 19440623

Conformational behaviour determines the low-relaxivity state of a conditional MRI contrast agent.

Ugo Cosentino1, Demetrio Pitea, Giorgio Moro, Gloria A A Saracino, Alessandra Villa.   

Abstract

The conformational behaviour in aqueous solution of the EgadMe complex, a conditional gadolinium-based contrast agent sensitive to beta-galactosidase enzymatic activity, is investigated by means of ab initio calculations and classical molecular dynamics simulations. Furthermore, force field parameterization of gadolinium-ligand interactions is performed, and its reliability is tested on the bench mark [Gd(DOTA)](-) system by MD simulations. Both computational methods highlight the presence in EgadMe of two main conformational isomers. The lowest energy conformation is a "close" form, corresponding to a state of low-relaxivity (MRI "inactive"), in which the ninth coordination site of the gadolinium ion is occupied by one oxygen atom of the galactopyranose residue. The second isomer, which is 2.9 (at ab initio level) and 4.2 (at MD level) kcal mol(-1) above the global minimum, presents an "open" form, corresponding to a state of high-relaxivity (MRI "active") in which one water molecule coordinates the ion. These results are consistent with experimental findings reported for EgadMe, and show that competition at the ninth coordination site of gadolinium ion, between the intra (the galactopyranose residue) and inter (water molecules) molecular interactions, affects the relaxivity of this system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440623     DOI: 10.1039/b902049g

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  4 in total

1.  Does the environment around the H-cluster allow coordination of the pendant amine to the catalytic iron center in [FeFe] hydrogenases? Answers from theory.

Authors:  Toshiko Miyake; Maurizio Bruschi; Ugo Cosentino; Carole Baffert; Vincent Fourmond; Christophe Léger; Giorgio Moro; Luca De Gioia; Claudio Greco
Journal:  J Biol Inorg Chem       Date:  2013-06-23       Impact factor: 3.358

2.  A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.

Authors:  Ana Paula Candiota; Milena Acosta; Rui Vasco Simões; Teresa Delgado-Goñi; Silvia Lope-Piedrafita; Ainhoa Irure; Marco Marradi; Oscar Bomati-Miguel; Nuria Miguel-Sancho; Ibane Abasolo; Simó Schwartz; Jesús Santamaria; Soledad Penadés; Carles Arús
Journal:  J Nanobiotechnology       Date:  2014-04-05       Impact factor: 10.435

Review 3.  Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.

Authors:  Senthilkumar Kalimuthu; Ju Hye Jeong; Ji Min Oh; Byeong-Cheol Ahn
Journal:  Int J Mol Sci       Date:  2017-07-27       Impact factor: 5.923

4.  Molecular recognition of agonist and antagonist for peroxisome proliferator-activated receptor-α studied by molecular dynamics simulations.

Authors:  Mengyuan Liu; Lushan Wang; Xian Zhao; Xun Sun
Journal:  Int J Mol Sci       Date:  2014-05-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.